MOH — authorised 29 December 2005
- Marketing authorisation holder: CUMBERLAND PHARMS
- Status: likely_approved
MOH authorised Vaprisol In 5% Dextrose In Plastic Container on 29 December 2005
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 29 December 2005.
CUMBERLAND PHARMS holds the Israeli marketing authorisation.